Common variable immunodeficiency: A multifaceted and puzzling disorder

Expert Review of Clinical Immunology

Volumn 5, Issue 2, 2009, Pages 167-180

  Bergbreiter, Astrid ^a   Salzer, Ulrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibody deficiency; B cell; BAFF R; CD19; Common variable immunodeficiency; Hypogammaglobulinemia; ICOS; TACI

Indexed keywords

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BAFF R GENE; CD19 GENE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE CLASSIFICATION; DNA POLYMORPHISM; GENE; GENETIC DISORDER; HUMAN; ICOS GENE; IMMUNOGLOBULIN DEFICIENCY; MSH5 GENE; PATHOGENESIS; PHENOTYPE; RECURRENT INFECTION; REVIEW; RISK FACTOR; T LYMPHOCYTE; TACI GENE;

EID: 77649174075     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.5.2.167     Document Type: Review

References (122)

1. Geha RS, Notarangelo LD, Casanova JL et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 120, 776-794 (2007).
2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin. Immunol. 93, 190-197 (1999).
3. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92, 34-48 (1999).
4. Chapel H, Lucas M, Lee M et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112, 277-286 (2008).
5. Warnatz K, Denz A, Dräger R et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99, 1544-1551 (2002).
6. Wehr C, Kivioja T, Schmitt C et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111, 77-85 (2008).
7. Bonilla FA, Bernstein IL, Khan DA et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 94(Suppl. 1), 1-63 (2005).
8. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin. Exp. Immunol. 118(Suppl. 1), 1-28 (1999).
9. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 27, 497-502 (2007).
10. Oksenhendler E, Gérard L, Fieschi C et al. Infections in 252 patients with common variable immunodeficiency. Clin. Infect. Dis. 46, 1547-1554 (2008).
11. Quinti I, Soresina A, Spadaro G et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J. Clin. Immunol. 27, 308-316 (2007).
12. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J. Clin. Pathol. 58, 546-547 (2005).
13. Sánchez-Ramón S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin. Immunol. 128, 314-321 (2008).
14. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin. Immunol. 120, 310-318 (2006).
15. Samuelson A, Borrelli S, Gustafson R et al. Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations. Scand. J. Infect. Dis. 27, 303-313 (1995).
16. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9, 334-356 (1987).
17. Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am. J. Surg. Pathol. 20, 1240-1252 (1996).
18. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am. J. Surg. Pathol. 31, 1800-1812 (2007).
19. Ward C, Lucas M, Piris J, Collier J, Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin. Exp. Immunol. 153, 331-337 (2008).
20. Malamut G, Ziol M, Suarez F et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J. Hepatol. 48, 74-82 (2008).
21. Michel M, Chanet V, Galicier L et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 81, 254-263 (2004).
22. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J. Autoimmun. 25, 57-62 (2005).
23. Sève P, Bourdillon L, Sarrot-Reynauld F et al. Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore) 87, 177-184 (2008).
24. Zhang L, Radigan L, Salzer U et al. Transmembrane activator and calciummodulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunological outcomes in heterozygotes. J. Allergy Clin. Immunol. 120, 1178-1185 (2007).
25. Salzer U, Bacchelli C, Buckridge S et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood DOI: blood- 2008-02-141937v1 (2008) (Epub ahead of print).
26. Morimoto Y, Routes JM. Granulomatous disease in common variable immunodeficiency. Curr. Allergy Asthma Rep. 5, 370-375 (2005).
27. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J. Allergy Clin. Immunol. 114, 415-421 (2004).
28. Wheat WH, Cool CD, Morimoto Y et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J. Exp. Med. 202, 479-484 (2005).
29. Mellemkjaer L, Hammarstrom L, Andersen V et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin. Exp. Immunol. 130, 495-500 (2002).
30. Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am. J. Hematol. 6, 171-178 (2002).
31. Zullo A, Romiti A, Rinaldi V et al. Gastric pathology in patients with common variable immunodeficiency. Gut 45, 77-81 (1999).
32. Vorechovsky I, Scott D, Haeney MR, Webster DA. Chromosomal radiosensitivity in common variable immune deficiency. Mutat. Res. 290, 255-264 (1993).
33. Aghamohammadi A, Moin M, Kouhi A et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 213, 447-454 (2008).
34. Piqueras B, Lavenu-Bombled C, Galicier L et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23, 385-400 (2003).
35. Giovannetti A, Pierdominici M, Mazzetta F et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J. Immunol. 178, 3932-3943 (2007).
36. Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Curr. Opin. Allergy Clin. Immunol. 5, 504-509 (2005).
37. Holm AM, Sivertsen EA, Tunheim SH et al. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7- effector-memory T cells. Clin. Exp. Immunol. 138, 278-289 (2004).
38. Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS. Abnormal interleukin-7 function in common variable immunodeficiency. Blood 105, 2887-2890 (2005).
39. Viallard JF, Blanco P, André M et al. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin. Immunol. 119, 51-58 (2006).
40. Raeiszadeh M, Kopycinski J, Paston SJ et al. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin. Exp. Immunol. 146, 234-242 (2006).
41. Holm AM, Tjønnfjord G, Yndestad A et al. Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia. Clin. Exp. Immunol. 144, 418-424 (2006).
42. Paccani SR, Boncristiano M, Patrussi L et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 106, 626-634 (2005).
43. Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29, 127-137 (2008).
44. Aspalter RM, Eibl MM, Wolf HM. Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency. J. Allergy Clin. Immunol. 120, 1193-1200 (2007).
45. Kanegane H, Tsukada S, Iwata T et al. Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry. Clin. Exp. Immunol. 120, 512-517 (2000).
46. Weston SA, Prasad ML, Mullighan CG, Chapel H, Benson EM. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin. Exp. Immunol. 124, 465-469 (2001).
47. Gaspar HB, Conley ME. Early B cell defects. Clin. Exp. Immunol. 119, 381-389 (2000).
48. Warnatz K, Bossaller L, Salzer U et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107, 3045-3052 (2006).
49. Warnatz K, Salzer U, Gutenberger S et al. Finally found: human BAFF-R deficiency causes hypogammaglobulinemia. Clin. Immunol. 115(Suppl. 1), 820 (2005).
50. Brouet JC, Chedeville A, Fermand JP, Royer B. Study of the B cell memory compartment in common variable immunodeficiency. Eur. J. Immunol. 30, 2516-2520 (2000).
51. Agematsu K, Futatani T, Hokibara S et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin. Immunol. 103, 34-42 (2002).
52. Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin. Immunol. 116, 37-41 (2005).
53. Vodjgani M, Aghamohammadi A, Samadi M et al. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J. Investig. Allergol. Clin. Immunol. 17, 321-328 (2007).
54. Detková D, de Gracia J, Lopes-da-Silva S et al. Common variable immunodeficiency: association between memory B cells and lung diseases. Chest 131, 1881-1889 (2007).
55. Berglund LJ, Wong SW, Fulcher DA. B-cell maturation defects in common variable immunodeficiency and association with clinical features. Pathology 40, 288-294 (2008).
56. Bonhomme D, Hammarstrom L, Webster D et al. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J. Immunol. 165, 4725-4730 (2000).
57. Andersen P, Permin H, Andersen V et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 105, 511-517 (2005). (Pubitemid 40070729)
58. Schejbel L, Marquart H, Andersen V et al. Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infection than lack of memory B cells in common variable immunodeficiency. J. Clin. Immunol. 25, 392-403 (2005). (Pubitemid 41204264)
59. Taubenheim N, von Hornung M, Durandy A et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. J. Immunol. 175, 5498-5503 (2005).
60. Cuss AK, Avery DT, Cannons JL et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 176, 1506-1516 (2006).
61. Litinskiy MB, Nardelli B, Hilbert DM et al. DCs induce CD40-independent immunoglobulin class switching through Blys and APRIL. Nat. Immunol. 3, 822-829 (2002).
62. Poeck H, Wagner M, Battiany J et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103, 3058-3064 (2004).
63. Cunningham-Rundles C, Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin. Immunol. 115, 147-153 (2005).
64. Bayry J, Lacroix-Desmazes S, Kazatchkine MD et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 101, 2441-2443 (2004).
65. Scott-Taylor TH, Green MR, Eren E, Webster AD. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin. Exp. Immunol. 138, 484-490 (2004).
66. Viallard JF, Camou F, André M et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res. Ther. 7, R1052-R1055 (2005).
67. Yong PF, Workman S, Wahid F, Exley A, Webster AD, Ibrahim MA. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin. Immunol. 127, 34-42 (2008).
68. Cunningham-Rundles C, Radigan L, Knight AK, Zang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immunodeficiency. J. Immunol. 176, 1978-1987 (2006).
69. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202 (2002).
70. Vorechovsky I, Zetterquist H, Paganelli R et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin. Immunol. Immunopathol. 77, 185-192 (1995).
71. Aghamohammadi A, Farhoudi A, Moin M et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin. Diagn. Lab. Immunol. 12, 825-1812 (2005).
72. Kralovicova J, Hammarstrom L, Plebani A, Webster AD, Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170, 2765-2775 (2003).
73. Finck A, van der Meer JW, Schäffer AA et al. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur. J. Hum. Genet. 14, 867-875 (2006).
74. Schaffer AA, Pfannstiel J, Webster AD, Plebani A, Hammarstrom L, Grimbacher B. Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum. Genet. 118, 725-729 (2006).
75. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4, 261-268 (2003).
76. Salzer U, Maul-Pavicic A, Cunningham-Rundles C et al. ICOS deficiency in patients with common variable immunodeficiency. Clin. Immunol. 113, 234-240 (2004).
77. Salzer U, Chapel HM, Webster AD et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37, 820-828 (2005).
78. Castigli E, Wilson SA, Garibyan L et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37, 829-1814 (2005).
79. van Zelm MC, Reisli I, van der Burg M et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354, 1901-1912 (2006).
80. Sekine H, Ferreira RC, Pan-Hammarström Q et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc. Natl Acad. Sci. USA 101, 7193-7198 (2007). (Pubitemid 47186031)
81. Hutloff A, Dittrich AM, Beier KC et al. ICOS is an inducible T-cell co-stimulator, structurally and functionally related to CD28. Nature 397, 263-266 (1999).
82. Beier KC, Hutloff A, Dittrich AM et al. Induction, binding specificity and function of human ICOS. Eur. J. Immunol. 30, 3707-3717 (2000).
83. McAdam AJ, Greenwald RJ, Levin MA et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409, 102-105 (2001).
84. Tafuri A, Shahinian A, Bladt F et al. ICOS is essential for effective T-helper-cell responses. Nature 409, 105-109 (2001).
85. Ohm-Laursen L, Schjebel L, Jacobsen K, Permin H, Svejgaard A, Barington T. Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency. Scand. J. Immunol. 61, 566-574 (2005).
86. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105, 1881-1890 (2005).
87. Bossaller L, Burger J, Draeger R et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 177, 4927-4932 (2006).
88. Akiba H, Takeda K, Kojima Y et al. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 175, 2340-2348 (2005).
89. Ebert LM, Horn MP, Lang AB, Moser B. B cells alter the phenotype and function of follicular-homing CXCR5+ T cells. Eur. J. Immunol. 34, 3562-3571(2004).
90. Lohning M, Hutloff A, Kallinich T et al. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197, 181-193 (2003).
91. Chtanova T, Tangye SG, Newton R et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173, 68-78 (2004).
92. Nurieva RI, Chung Y, Hwang D et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138-149 (2008).
93. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
94. Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL, a tutorial on B cell survival. Annu. Rev. Immunol. 21, 231-264 (2003). (Pubitemid 37174532)
95. Castigli E , Wilson SA , Scott S et al. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201, 35-39 (2005).
96. He B, Xu W, Santini PA et al. Intestinal bacteria trigger T cell-independent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007).
97. Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 109, 2961-2967 (2007).
98. Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur. J. Immunol. 37, 110-118 (2007).
99. von Bülow GU, van Deursen JM, Bram RJ. Regulation of the T independent humoral response by TACI. Immunity 14, 573-582 (2001).
100. Yan M, Wang H, Chan B et al. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2, 638-643 (2001).
101. Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18, 279-288 (2003).
102. Pan-Hammarström Q, Salzer U, Du L et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat. Genet. 39, 429-430 (2007).
103. Kanegane H, Agematsu K, Futatani T et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 8, 663-670 (2007).
104. Smet J, van Zelm M, van der Burg M et al. Hypogammaglobulinemia associated with a novel CD19 mutation. Clin. Exp. Immunol. 154, 81, P108 (2008).
105. Schiemann B, Gommerman JL, Vora K et al. An essential role for BAFF in the normal development of B cells through a BCMA independent pathway. Science 293, 2111-2114 (2001).
106. Gross JA, Dillon SR, Mudri S et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15, 289-302 (2001).
107. Thompson JS, Bixler SA, Qian F et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108-2111 (2001).
108. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptordependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173, 2245-2252 (2004).
109. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-α polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J. Immunol. 159, 6236-6241 (1997).
110. Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand. J. Immunol. 51, 111-122 (2000).
111. Litzman J, Freiberger T, Grimbacher B et al. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin. Exp. Immunol. 153, 324-330 (2008).
112. Losi CG, Salzer U, Gatta R et al. Mutational analysis of human BLyS in patients with common variable immunodeficiency. J. Clin. Immunol. 26, 396-399 (2006).
113. Salzer U, Neumann C, Thiel J et al. Screening of functional and positional candidate genes in families with common variable immunodeficiency. BMC Immunol. 9, 3 (2008).
114. Losi CG, Silini A, Fiorini C et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J. Clin Immunol. 25, 496-502 (2005).
115. Orange JS, Hossny EM, Weiler CR et al.; Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J. Allergy Clin. Immunol. 117, S525-S553 (2006).
116. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1, 1075-1077 (1987).
117. Eijkhout HW, van Der Meer JW, Kallenberg CG et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann. Intern. Med. 135, 165-174 (2001).
118. Sewell WA, Buckland M, Jolles SR. Therapeutic strategies in common variable immunodeficiency. Drugs 63, 1359-1371 (2003).
119. Hatab AZ, Ballas ZK. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J. Allergy Clin. Immunol. 116, 1161-1162 (2005).
120. Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann. Allergy Asthma Immunol. 95, 293-300 (2005).
121. Carbone J, Escudero A, Mayayo M et al. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann. NY Acad. Sci. 1051, 666-671 (2005).
122. Wakim M, Shah A, Arndt PA et al. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am. J. Hematol. 76, 152-155 (2004).